Physician profile
Todd Hill
NPI 1518947506
$830.76
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $228 · 2022: $387 · 2023: $88.86 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $301.05 | 2021-2022 | |
| Bausch Health US, LLC | $225.93 | 2021-2022 | |
| Alkermes, INC. | $90.11 | 2023-2024 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.63 | 2023-2024 | Caplyta |
| Abbvie INC. | $31.78 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $29.01 | 2024 | Rexulti, Abilify Maintena |
| Sage Therapeutics, LLC | $28.21 | 2024 | |
| Supernus Pharmaceuticals, INC. | $24.81 | 2022 | |
| Biogen, INC. | $17.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.